BioSpace News Archive

Press Releases

Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic

June 30, 2026
·
8 min read
Press Releases

SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

June 30, 2026
·
4 min read
Press Releases

Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors

June 30, 2026
·
7 min read
Press Releases

Protagenic Therapeutics’ Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model

June 30, 2026
·
4 min read
Press Releases

STARMED Becomes First Company to Receive FDA Clearance for Radiofrequency Ablation of Thyroid Nodules in the United States

June 30, 2026
·
2 min read
Press Releases

Aurenar Receives FDA Breakthrough Device Designation for Non-Invasive Neuromodulation Therapy Designed for the Reduction of Cerebral Vasospasm Following Brain Hemorrhage

June 30, 2026
·
4 min read
Press Releases

Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs

June 30, 2026
·
3 min read
Press Releases

Exact Imaging Expands U.S. Commercial Team to Meet Growing Demand for Its Micro-Ultrasound Technology for Prostate Cancer

June 30, 2026
·
2 min read
Press Releases

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder

June 30, 2026
·
11 min read
Press Releases

Stoke Therapeutics Announces Completion of Enrollment of 162 Patients Into the Phase 3 EMPEROR Study of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome

June 30, 2026
·
10 min read